Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Retained Earnings (2016 - 2026)

Angiodynamics' Retained Earnings history spans 16 years, with the latest figure at -$454.5 million for Q1 2026.

  • For Q1 2026, Retained Earnings fell 7.42% year-over-year to -$454.5 million; the TTM value through Feb 2026 reached -$454.5 million, down 7.42%, while the annual FY2025 figure was -$2.0 million, 53.65% up from the prior year.
  • Retained Earnings reached -$454.5 million in Q1 2026 per ANGO's latest filing, down from $998000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $998000.0 in Q4 2025 to a low of -$454.5 million in Q1 2026.
  • Average Retained Earnings over 5 years is -$103.5 million, with a median of -$4.4 million recorded in 2024.
  • Peak YoY movement for Retained Earnings: tumbled 20542.5% in 2023, then skyrocketed 126.63% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$288000.0 in 2022, then tumbled by 1534.72% to -$4.7 million in 2023, then rose by 20.39% to -$3.7 million in 2024, then surged by 126.63% to $998000.0 in 2025, then plummeted by 45644.49% to -$454.5 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Retained Earnings are -$454.5 million (Q1 2026), $998000.0 (Q4 2025), and $61000.0 (Q3 2025).